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Summary 
 
BACKGROUND: Medication-related incidents are an important consideration in 
enhancing patient safety in hospital care. The wide utilisation of antimicrobial therapy 
in this population renders these medications particularly vulnerable to errors and 
adverse events. 
AIM: To analyse the characteristics of antimicrobial therapy-related incident reports 
across a group of secondary care hospitals. 
METHODS: Reports for antimicrobial-related incidents from April 2010 to December 
2013 were obtained from a regional area of hospitals in National Health Service 
(NHS) Scotland. Reports were analysed at-large, with subset analyses of incidents 
resulting in patient harm/injury and those included in a multivariable regression 
adjusted by occupied bed days (OBD) and defined daily doses (DDD) to better 
ascertain areas to target for antimicrobial safety. 
FINDINGS: A total of 1345 incidents were reported at a crude rate of 0.98 
reports/day (95% CI: 0.93-1.03 reports/day). Penicillins (371 reports; 27.6%), 
aminoglycosides (358; 26.6%) and glycopeptides (210; 15.6%) were the most 
commonly involved classes of medications. Most incidents involved no injury/harm 
(514; 38.2%), but 72 reports (5.4%) did result in patient harm. 
Rehabilitation/Assessment (RR: 2.61, 95% CI: 1.70-4.03) and Women/Childrens 
(RR: 2.61, 95% CI: 1.70-4.03) had higher incident reporting rates compared to other 
hospital services, likely as a function of at-risk patient populations. Among the types 
of incidents reported, those involving issues with administration/supply were most 
common (RR: 2.07, 95% CI: 1.51-2.84). 
4 
 
CONCLUSION: Incident reporting for antimicrobials identified several key areas for 
quality improvement in the hospital setting which can guide safety efforts.
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Main text 
 
INTRODUCTION: 
 
Patient safety incident reporting is recognised as an important quality improvement 
measure and a focus for the delivery of healthcare. In 2005, it was estimated that 
patient safety incidents resulted in additional yearly costs to the National Health 
Service (NHS) in the United Kingdom (UK) of £2 billion in extra hospital bed days 
and £1 million in treating hospital-acquired infections; medication errors were found 
to be the second most commonly reported incident behind patient injury due to falls.1 
The number of medication incident reports in England/Wales increased from 
approximately 42,000 in 2005 to over 132,000 in 2010.2  
 
Although reports indicate the presence of undesired incidents, increased reporting in 
itself can be considered a positive trend as it is known that the number of actual 
events greatly surpasses the reports made, and overcoming clinician barriers to 
making reports is a key step in improving medication use.3 For instance, reporting 
rates in the acute care setting have been positively correlated with hospital staff 
perceptions of positive safety culture at their institution.4 In the UK, two patient safety 
alerts were released regarding incident reporting for medications and medical 
devices and the formation of national networks to enhance understanding and 
prevention of these events.5 
 
Antimicrobial agents are some of the most widely prescribed medications in 
healthcare across the world.6 Due to their extensive utilisation across the clinical 
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spectrum, their prescribing is especially vulnerable to errors and adverse events. An 
analysis of over 21,000 adverse drug events in outpatients in the United States 
(USA) identified the top three responsible medications as insulin, warfarin and 
amoxicillin; antibiotics were responsible for 7 of the top 18 implicated medications.7 
Two analyses of medication-related incidents in UK hospitals found that between 
13.1 and 14.3% of incidents involved antimicrobials.8,9 Events involving antibiotics 
can occur across all stages of the medication use spectrum and have potential for 
serious consequences, particularly with regard to prescribing without consideration 
of allergy status, or delayed or missed administration in the case of life-threatening 
infections.  
 
Traditionally, the focus on antimicrobial utilisation has been on limiting inappropriate 
use through stewardship to protect against the unnecessary development of 
resistance; however, this fails to fully capture the whole spectrum of utilisation. In 
depth analysis of medication errors associated with antimicrobials although limited is 
an important contributor to the understanding of this class of high-risk and widely 
utilised medications. Therefore, the objective of the present study was to analyse the 
characteristics of voluntary incident reporting relating to antimicrobial therapies 
across a regional group of secondary care hospitals in the West of Scotland. 
 
METHODS:  
 
Setting and data 
The study was a retrospective analysis of Datix incident reports involving 
antimicrobials. Datix is a web-based software tool utilised for the collection, analysis 
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and dissemination of information related to patient safety and risk management; 
approximately three-quarters of the NHS in the UK utilises the software in this 
capacity.10 The tool is available for a variety of uses, including reporting of incidents 
by clinicians (medication-related or otherwise), or for patient experience/feedback, 
malpractice claims management or institutional self-assessment.10 
 
The data extract from Datix was limited to medication-related incident reports 
submitted from a single regional health board in Scotland, serving a population of 
approximately 1.2 million people. Data were exported for a 15-quarter time period 
(April 2010 to December 2013) for participating institutions within the health board 
area. Reports were limited to include only those associated with systemic 
medications for infection listed in Chapter 5 of the British National Formulary (BNF), 
including sub-sections on antibacterial, antifungal, antiviral, antiprotozoal and 
anthelmintic medications.11 Data columns of interest included hospital directorate (a 
coordinated group of related clinical specialties), medication administered, and 
incident date, sub-category, stage, description, action taken, result and severity. All 
characteristic variables were categorical in nature (Table I) with the exception of the 
medication administered and incident description/action taken, which included 
subjective text from the reporter. Incident result was consolidated from 19 categories 
in Datix to 5 user-defined categories to facilitate analysis. No ethics approval was 
deemed necessary to conduct the present study. 
 
Overall analysis 
Data were first evaluated as a function of total raw reports from the complete data 
extract and were broadly described among available variables. Medications 
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administered during the incident were grouped into corresponding BNF sub-sections 
ZLWKWKHH[FHSWLRQRIµ6RPHRWKHUDQWLEDFWHULDOV¶ for which vancomycin and 
teicoplanin were analysHGVHSDUDWHO\DVµJO\FRSHSWLGHV¶.11 A further in-depth analysis 
regarding incidents resulting in patient harm was conducted utilising incident sub-
categories and narratives from the report submitter in the incident description. 
Specific clinical outcomes from incidents were not included to maintain patient 
confidentiality. 
 
Adjusted analysis 
Data were secondarily analysed in an adjusted subset analysis to better assess 
relative prevalence of events; to achieve this, the Datix extract was supplemented 
with a second dataset of occupied bed day (OBD) to assess occupancy and defined 
daily dose (DDD) figures to assess medication utilisation for the regional area. Data 
for OBD and DDD (limited to BNF Chapter 5 medications for infection) were provided 
annually for calendar years 2010 through 2013, subdivided by hospital facility and 
directorate, although they were only available for a subset of the largest 10 hospitals 
and 6 hospital directorates. A negative binomial regression was applied using 
hospital directorate, incident year, incident stage and incident result as predictors of 
number of reports. The Datix extract was limited to the selected hospitals and 
hospital directorates available in the OBD/DDD dataset; this subset was 
subsequently matched to the secondary dataset, using DDDs/1000 OBDs as the 
offset variable. Pharmacy Services as a hospital unit did not have figures available 
for OBD/DDD, but as their services cover the entirety of the facility, the sum of other 
directorates was utilised. While OBD were available for 2010-2013 inclusive, reliable 
tracking of DDD was not available within the health board until 2011. Therefore, 
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DDDs for calendar year 2010 were back-extrapolated using linear trend from 2011-
2014. Lastly, a 25% adjustment applied to OBD/DDD figures for 2010 to account for 
the three quarters of Datix reporting in 2010. 
 
Statistical analysis 
The analysis was performed using IBM SPSS Statistics 21 (IBM; Armonk, NY, USA). 
7KHĮ-significance level for all tests was set at 0.05. Variables in the regression were 
assessed on a singular basis, followed by inclusion of significant variables within a 
final multivariable model. Results were displayed using relative rates (RR) and 95% 
confidence intervals (CI).  
 
RESULTS:  
 
Overall analysis 
A total of 1345 Datix reports on incidents related to antimicrobials were recorded 
between April 2010 and December 2013 in our regional analysis, at a crude rate of 
0.98 reports/day (95% CI: 0.93-1.03 reports/day). The number of reports each year 
was relatively stable at 1.04 reports/day (2010), 0.95 reports/day (2011), 0.93 
reports/day (2012) and 1.01 reports/day (2013). Ten hospitals contributed reports 
within the timeframe: two of which contributed approximately 30% of reports and the 
rest were divided among the remaining 8 facilities. Three directorates accounted for 
approximately three-quarters of reports ± Emergency/Medical (385; 28.6%), 
Women/Childrens (332; 24.7%) and Surgery/Anaesthetics (273; 20.3%) ± with 
Rehabilitation/Assessment (145; 10.8%), Pharmacy Services (78; 5.8%) and 
Regional Services (76; 5.6%) constituting the majority of the remainder. Remaining 
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directorates (Diagnostics, Health/Community Care, Mental Health, and Sexual 
Health) represented less than 5% of reports collectively. 
 
Reports concerning medication administration/supply (673; 50.0%) represented the 
largest group under incident stage, followed by prescribing (342; 25.4%). Preparation 
(97; 7.2%), monitoring (74; 5.5%) and advice (20; 1.5%) were less common; 
however, a total of 138 reports (1ZHUHFODVVLILHGDVµRWKHU¶ which included 
multi-stage incidents, environmental hazards, patient-prompted events or those 
unable to be classified under the aforementioned categories by the reporter. Incident 
results were most frequently classified as resulting in no injury/harm (514; 38.2%), 
followed by change/delay in treatment (285; 21.3%), near miss (187; 13.9%), or 
KDUPDWRWDORIUHSRUWVZHUHFODVVLILHGDVµRWKHU¶ Among the 
µRWKHU¶incident results, 274 (95.5%) reports ZHUHFRGHGDVµXQDEOHWRDVVHVV
RXWFRPH¶ The most common incident severity rating was minor (642; 47.7%), 
followed by negligible (443; 32.9%), moderate (223; 16.6%) and major (8; 0.6%). No 
severe errors were reported, and 29 reports (2.2%) had no severity rating attached. 
 
A total of 1300 reports (96.7%) denoted a single class of antimicrobial involved in the 
incident, with the remainder involving 2 or 3 classes simultaneously; the most 
common combinations were aminoglycosides/penicillins (9 reports) and 
aminoglycosides/glycopeptides (6 reports). Overall, penicillins and aminoglycosides 
were the most commonly involved classes of medications at 371 reports (27.6%) and 
358 reports (26.6%), respectively (Figure 1). Glycopeptides contributed a further 210 
reports (15.6%). The most commonly identified agents in each of these classes were 
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amoxicillin (126 reports; 34.0% of class), gentamicin (344 reports; 96.1% of class) 
and vancomycin (189 reports; 90.0% of class). 
 
Incidents associated with harm 
A total of 72 reports involved harm/injury to the patient. Thirteen reports (18.1%) 
involved scenarios where antimicrobials were administered to patients with 
known/documented allergies; almost all of these cases involved penicillins (10 
reports; 76.9% of group). Nine reports (12.5%) noted omissions of antimicrobial 
therapy where it was felt to have contributed to prolonged infection or hospital stay. 
Twenty-WZRUHSRUWVLQYROYHGVRPHW\SHRIµZURQJ¶HYHQWHJGRVH
frequency, strength, patient, etc.), the most common of which was wrong dose (7 
reports) or wrong drug (5 reports). Five reports (6.9%) were related to extravasation 
of intravenous medication. The most commonly involved medication classes were 
penicillins (45 reports; 62.5%) and aminoglycosides (13 reports; 18.1%). 
 
Adjusted analysis 
Using the available subset of reports (constraints applied to hospital, hospital 
directorate and incident stage) corresponding to OBD/DDD figures provided 1081 
reports (80.4% of total) available for adjusted analysis with an overall adjusted rate 
of 1.83 reports per 10,000 OBDs (95% CI: 1.72-1.93) or 1.12 reports per 10,000 
DDDs (95% CI: 1.05-1.19). Descriptive characteristics of this subset were largely 
similar to the full extract. Incidents regarding administration/supply (616; 57.0%) 
resulting in no harm/injury (435; 40.2%) and of minor severity rating (511; 47.3%) 
were again most common. Emergency/Medical (334; 30.9%), Women/Childrens 
(301; 27.8%) and Surgery/Anaesthetics (241; 22.3%) remained the top directorates 
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reporting. When adjusted, Women/Childrens had a significantly higher reporting rate 
based on both occupancy (5.59 reports per 10,000 OBDs) and utilisation (4.43 
reports per 10,000 DDDs) compared to other directorates, followed by 
Surgery/Anaesthetics (1.98 and 1.30 reports per 10,000 OBDs and DDDs, 
respectively). Emergency/Medical services had an elevated reporting rate driven by 
utilisation (1.89 vs. 0.61 reports per 10,000 OBDs and DDDs, respectively) while 
Rehabilitation had elevated reporting driven by occupancy (0.51 vs. 1.48 reports per 
10,000 OBDs and DDDs, respectively.  
 
The regression analysis (adjusted for both OBDs and DDDs) found that 
Rehabilitation/Assessment (RR: 2.61, 95% CI: 1.70-4.03) and Women/Childrens 
(RR: 2.61, 95% CI: 1.70-4.03) were most likely to report incidents on antimicrobials 
and that administration/supply incidents were most common (RR: 2.07, 95% CI: 
1.51-2.84) (Table II). Incidents involving no harm to the patient were most likely and 
those resulting in some form of harm were least likely among all results (RR: 0.12, 
95% CI: 0.07-0.19). Although the number of reports demonstrated a trend toward an 
increase from 2010 to 2013, this effect was not significant and was not included in 
the final model. 
 
DISCUSSION: 
 
This retrospective study on hospital medication incident reporting was the first study, 
to our knowledge, to report on the specific characteristics of antimicrobial incidents 
using an adjusted approach. This analysis also directly contributes to national goals 
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for identifying trends and actions in medication error incident reporting to improve 
patient safety.5 
 
Limited data are available on the extent of antimicrobials as a proportion of total 
medication incidents, but international estimates from Saudi Arabia (20.5%)12, 
Greece (16.5%)13 and the USA (17.6%)14 are broadly comparable to those found in 
the UK (14.3%8 and 13.1%9) and indicate the importance of evaluating the 
characteristics of these reports more in depth. Characteristics of antimicrobial errors 
may not necessarily mirror those of medication errors at-large; a previous analysis of 
Datix reports across all medications in a separate group of Scottish hospitals 
associated prescribing with only 10.8% of reports,15 whereas the rate among 
antimicrobials in this study was over twice that estimate at 25.4%. Therefore, 
education and optimisation in prescribing practices (via clinician in-services and 
prescribing nomograms) may represent a specific focus for improvement in the use 
of antimicrobials compared to the overall spectrum of medication use. 
 
A total of 5.4% of reports on antimicrobials involved incidents causing harm/injury, 
similar to the 6% identified among medications at-large in Scotland.15 A significant 
proportion of these errors involved administration of penicillins to patients with known 
allergies (13.9% of harm-resulting events and 37.0% of penicillin-related harm 
events), which is a highly preventable event. A survey of clinicians in England 
identified knowledge gaps as a significant contributor to medication errors in 
penicillin-allergic patients; only 55.9% of respondents considered themselves 
knowledgeable about which antibiotics contain penicillin and 87.7% consider a lack 
RINQRZOHGJHDQLVVXHDPRQJµVRPH¶RUµPRVW¶of their colleagues.16 Targeted efforts 
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in education after identification of problems through clinical audit have been shown 
to significantly improve practice and potentially reduce patient harm,17 demonstrating 
these incidents to be preventable. A recent initiative in the health board from this 
analysis produced an information poster highlighting which specific antibiotics are 
associated with penicillin allergies; the effects of this scheme will be measured using 
future incident data. 
 
The regression model was utilised as both patient occupancy and medication 
utilisation may feasibly affect incident reporting rates, although not in linear or 
singular fashion. Rehabilitation/Assessment and Emergency Care/Medical had the 
similarly highest occupancy among the directorates assessed (approximately 1.8 
million OBDs each over the study period); while Emergency Care/Medical had over 8 
times the amount of antimicrobials used during this time period (5.5 million vs 
650,000 DDDs), its reporting rate was only 3.5 times higher. However, 
Women/Childrens, which had similar antimicrobial use to Rehabilitation/Assessment 
(approximately 675,000 DDDs each), had 3 times as many reports submitted. 
 
Women/Childrens services had the highest reporting rates among directorates as a 
function of both occupancy and utilisation. This is likely driven by the paediatric 
component of the service, which has been shown to have higher rates of incident 
reporting and prescribing errors in previous analyses from the UK9 and Spain.18 
Indeed, post hoc exploration of the events in our analysis estimated that services for 
children represented 81% of events from the combined Women/Childrens division 
(data not shown), in line with these previous data. Children are subject to a higher 
degree of risk in medication use due to complex dosing schemes/calculations and 
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unique drug metabolism compared to adult patients.19 Due to this heighted risk, 
reporting for these patients may also be better engrained in the clinician culture to 
promote safety or documentation for the purposes of potential litigation. Similarly, the 
regression model revealed a higher risk of reporting among the 
Rehabilitation/Assessment directorate, which includes services for rehabilitation, 
geriatric medicine and palliative care. The latter end of the age spectrum contributes 
a unique set of risk factors for medication-related incidents, including complexity of 
health/disability, polypharmacy, diminished or disrupted renal/hepatic function, and 
lack of standardised recommendations in this population.20 However, the directorate 
had the lowest overall utilisation of antimicrobials, suggesting this was not the 
primary contributor to the incident rate. The high patient occupancy reflected by the 
OBDs in this directorate is likely driven by longer lengths of stay (as opposed to high 
throughput seen in Emergency Care/Medical), which lend better opportunity for 
incident occurrence, recognition and reporting.  
 
With regard to specific therapeutic agents, an estimate of most common antibiotics 
prescribed in Scottish hospitals identified the most common agents prescribed as 
amoxicillin (15.6%), co-amoxiclav (10.0%) and metronidazole (9.0%),21 of which only 
amoxicillin was involved in a high number of reports in this analysis (9.3%); in fact, 
gentamicin and vancomycin are estimated to represent 10.8% of antimicrobial 
prescribing in Scottish hospitals,21 but were involved in 39.6% of reports in this 
analysis. This is likely because gentamicin and vancomycin have narrow therapeutic 
windows, require therapeutic drug monitoring and have an enhanced environment of 
safety regarding their use.  
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As a retrospective study, this analysis is subject to limitations, such as lack of entry 
standardisation by multiple reporters and incomplete information for events. 
Additionally, the voluntary reporting of safety events is an important consideration. 
7KHUHLVDFRPSOH[LQWHUSOD\RIUHDVRQVEHKLQGDFOLQLFLDQ¶VFKRLFHWR contribute to 
voluntary incident reporting, including habit, social and cultural factors, perceived 
consequences, facilitating conditions and overall motivation.22 To complete an 
adjusted analysis, a subset of the data with corresponding OBD/DDD figures was 
utilised; although this subset appeared representative of the full extract, it has the 
potential to skew the results. Furthermore, there was no OBD/DDD estimate for 
Pharmacy Services because of its nature as a support service rather than an 
admitting patient service. Being that a pharmacy department provides services to the 
entire facility, the sum of all other OBD/DDD figures was utilised, resulting in an 
artificially low reporting rate. An alternative option would have been to exclude 
consideration of this service from the adjusted analysis; however, this would further 
limit the representativeness of the subset, and would almost entirely remove reports 
associated with preparation/dispensing, which were felt to be important to capture.  
 
In summary, antimicrobials should be considered an important focus in improving 
medication safety due to their widespread use across the clinical spectrum and 
significant contribution to medication-related incidents. In this regional analysis, 
increased rates of event reporting were identified among Women/Childrens and 
Rehabilitation/Assessment services, which follow-up will be needed to determine if 
this is a function of increased awareness for reporting or higher overall risk within 
antimicrobial use. However, targeting at-risk paediatric and elderly patients may 
provide a useful focus for efforts to enhance medication safety. Allergy-induced harm 
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events were also identified as an important area for quality improvement, and 
educational efforts in the health board will be measured to determine any reductions 
in these events. It is hoped that this regional experience identifying areas for quality 
improvement in hospital antimicrobial use can inform and stimulate a wider audience 
toward safer use of these medications. 
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TABLES 
Table I: Selected variables and categories in the Datix extract 
Variable Categories 
Hospital directorate 
 
Diagnostics 
Emergency/Medical  
Facilities/Estates 
Health/Community Care 
Mental Health 
Pharmacy Services 
Regional Services Á 
Rehabilitation/Assessment § 
Sexual Health 
Specialist Childrens 
Surgery/Anaesthetics 
Women/Childrens 
Incident stage 
Prescribing 
Preparation/dispensing 
Administration/supply 
Monitoring/follow-up 
Advice 
Supply/use of OTC medicine 
Other 
Incident result ¥ 
Change/delay to treatment 
Change to treatment 
Delay in treatment 
Harm/injury 
Critical condition 
Ill health 
Infection 
Pain/prolonged pain 
Patient distress 
Personal injury 
Prolonged stay in hospital 
Supportive treatment required 
Temporary deterioration 
Near miss 
Near miss by chance 
Near miss by intervention 
No harm 
No injury, harm or adverse outcome 
Other 
Disruption to services 
Financial loss 
Loss of property 
Referred to another service 
Unable to assess outcome 
Incident severity 
Negligible 
Minor 
Moderate 
Major 
Severe 
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 includes general medical services: cardiology, endocrinology, gastroenterology, 
respiratory medicine, rheumatology, dermatology and accident/emergency (A&E) 
ÁLQFOXGHVPHGLFDOVSHFLDOW\VHUYLFHVSODVWLFVQHSKURORJ\QHXURVXUJHU\QHXURORJ\
haematology/oncology  
§ includes rehabilitation, geriatric medicine and palliative care 
¥ upper-level designations denote user-defined categories, lower-level designations 
denote original Datix categories 
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Table II: Regression results for antimicrobial reports 
Variable 
Univariable model 
RR (95% CI) 
Adjusted model 
RR (95% CI) 
p-value 
(adjusted) 
Hospital directorate 
  
 
     Emergency/Medical 1 (reference) 1 (reference)  
     Regional Services 0.22 (0.14-0.34) 0.25 (0.16-0.41) <0.001 
     Pharmacy Services 0.35 (0.23-0.53) 0.62 (0.39-0.99) 0.046 
     Rehabilitation 2.59 (1.76-3.81) 2.61 (1.70-4.03) <0.001 
     Surgery/Anaesthetics 1.49 (1.04-2.11) 1.34 (0.91-1.98) 0.143 
     Women/Childrens 2.05 (1.45-2.90) 2.04 (1.39-2.99) <0.001 
Year 
  
 
     2010 1 (reference) 
N/A N/A 
     2011 0.92 (0.67-1.27) 
     2012 0.87 (0.63-1.20) 
     2013 0.95 (0.69-1.31) 
Incident stage 
  
 
     Prescribing 1 (reference) 1 (reference)  
     Preparation/dispensing 0.25 (0.17-0.35) 0.36 (0.24-0.54) <0.001 
     Administration/supply 2.04 (0.51-2.75) 2.07 (1.51-2.84) <0.001 
     Monitoring/follow-up 0.23 (0.16-0.33) 0.27 (0.19-0.40) <0.001 
Incident result 
  
 
     No harm 1 (reference) 1 (reference)  
     Near miss 0.34 (0.24-0.49) 0.45 (0.31-0.65) <0.001 
     Change/delay in treatment 0.45 (0.32-0.63) 0.47 (0.32-0.67) <0.001 
     Harm 0.09 (0.06-0.14) 0.12 (0.07-0.19) <0.001 
     Other 0.52 (0.37-0.73) 0.54 (0.38-0.78) 0.001 
 
CI: confidence interval; N/A: not applicable; RR: relative rate 
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FIGURE LEGEND 
 
Figure 1: Selected reports by medication class (with BNF classification) 
* Glycopeptides includes only vancomycin and teicoplanin listed in BNF sub-section 
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